SPIDI sub-biobank

Research Technology centers Radboud biobank News Biobank SPIDI sub-biobank

19 July 2022

The SPIDI collection aims to assess the prognostic value of MRI-DWI (new form of MRI research) and biomarkers (brain-specific proteins in cerebrospinal fluid) in the first 24 hours after the occurrence of a spinal cord injury as a result of trauma. The collections consists of cerebral spinal fluid (CSF) and associated clinical data.

Want to know more about these subjects? Click on the buttons below for more news.

Radboud Biobank

Related news items

TETRO-trial

30 March 2023

The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.

Archipelago

30 March 2023

Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.

EVA-trial

30 March 2023

The Department of Obstetrics and Gynecology established the EVA trial biobank with the aim of enabling scientific research into high blood pressure in pregnancy.

Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard

30 March 2023

In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.

Health-RI receives definitive follow-up funding from the National Growth Fund

30 March 2023

The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.

Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)

19 July 2022

The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.